Phylogica and University of Queensland receive grant for Phylomer®-based biosensor device

PERTH, AUSTRALIA: 4 July 2013 – Phylogica Ltd (ASX: PYC, XETRA: PH7), a leading Australian peptide drug discovery company, announced today that it will receive a Linkage Grant from the Australian Research Council (ARC) to collaborate with scientists at The University of Queensland’s Institute for Molecular Bioscience (IMB). The grant, which The University of Queensland applied for in conjunction with Phylogica, and which the University will administer, will provide funding of $402,614 for a project entitled: “A microfluidic array of Phylomers for rapid discovery of peptide probes and biomarkers.”

In this project, Phylogica and its collaborators at the IMB will exploit the unique structural diversity of Phylogica’s Phylomer libraries for biomarker discovery. The partners will jointly develop a single biosensor, displaying tens of thousands of synthetic Phylomers in a parallel format for screening in high throughput. A universal Phylomer array based on this platform will allow rapid identification of unique signatures for biomarker discovery from any biological sample. Such biomarker signatures may subsequently be used to develop diagnostic tests and to profile patients and their responses to particular treatments.

To read the full ASX announcement, please download the document below.